PEG filgrastim (pegfilgrastim biosimilar) / Harvest Moon - LARVOL DELTA

Factors associated with failure in mobilization of peripheral blood hematopoietic progenitor cells in autologous transplantation. (EBMT 2017) - "...G-CSF (Filgrastim), CFM 1.5 g/m2 + G-CSF, and Pegfilgrastim were used as the mobilization agent...Conclusions. The most important risk factors for poor mobilization are the underlying pathology, NHL is the most frequent followed by MM, the risk factors identified for poor mobilization in MM were the presence of Bone marrow fibrosis, Hemoglobin at diagnosis."

Biomarker • Clinical • Biosimilar • Fibrosis • Hematological Malignancies • Immunology • Leukemia • Lymphoma • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology